Balentine LLC’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12
| Closed | -$1.75K | – | 203 |
|
|
2024
Q3 | $1.75K | Hold |
12
| – | – | ﹤0.01% | 213 |
|
|
2024
Q2 | $1.65K | Hold |
12
| – | – | ﹤0.01% | 181 |
|
|
2024
Q1 | $1.65K | Hold |
12
| – | – | ﹤0.01% | 581 |
|
|
2023
Q4 | $1.63K | Hold |
12
| – | – | ﹤0.01% | 570 |
|
|
2023
Q3 | $1.47K | Sell |
12
-14
| -54% | -$1.71K | ﹤0.01% | 550 |
|
|
2023
Q2 | $3.3K | Buy |
26
+14
| +117% | +$1.78K | ﹤0.01% | 552 |
|
|
2023
Q1 | $1.55K | Hold |
12
| – | – | ﹤0.01% | 597 |
|
|
2022
Q4 | $1.58K | Sell |
12
-5
| -29% | -$656 | ﹤0.01% | 635 |
|
|
2022
Q3 | $2K | Hold |
17
| – | – | ﹤0.01% | 584 |
|
|
2022
Q2 | $2K | Hold |
17
| – | – | ﹤0.01% | 618 |
|
|
2022
Q1 | $2K | Hold |
17
| – | – | ﹤0.01% | 617 |
|
|
2021
Q4 | $3K | Hold |
17
| – | – | ﹤0.01% | 412 |
|
|
2021
Q3 | $3K | Hold |
17
| – | – | ﹤0.01% | 308 |
|
|
2021
Q2 | $3K | Sell |
17
-40
| -70% | -$7.06K | ﹤0.01% | 212 |
|
|
2021
Q1 | $9K | Buy |
57
+40
| +235% | +$6.32K | ﹤0.01% | 195 |
|
|
2020
Q4 | $3K | Hold |
17
| – | – | ﹤0.01% | 166 |
|
|
2020
Q3 | $2K | Buy |
+17
| New | +$2K | ﹤0.01% | 140 |
|
|
2018
Q1 | – | Sell |
-72
| Closed | -$23K | – | 262 |
|
|
2017
Q4 | $23K | Sell |
72
-144
| -67% | -$46K | ﹤0.01% | 363 |
|
|
2017
Q3 | $24K | Hold |
216
| – | – | ﹤0.01% | 366 |
|
|
2017
Q2 | $22K | Hold |
216
| – | – | ﹤0.01% | 358 |
|
|
2017
Q1 | $21K | Hold |
216
| – | – | ﹤0.01% | 339 |
|
|
2016
Q4 | $19K | Hold |
216
| – | – | ﹤0.01% | 333 |
|
|
2016
Q3 | $21K | Hold |
216
| – | – | ﹤0.01% | 274 |
|
|
2016
Q2 | $19K | Buy |
+216
| New | +$19K | ﹤0.01% | 255 |
|